Bayer wins EU approval for Lynkuet, expanding its pharma portfolio with a hormone-free treatment for moderate to severe ...
Bayer’s Lynkuet receives EU marketing approval to treat moderate to severe VMS associated with menopause or endocrine therapy for breast cancer: Berlin Thursday, November 20, 20 ...
ControlUp Migrate for Windows 365 will be available for free to everyone--ControlUp customers and non-customers alike--starting this week. Learn more and see the new tool in action at ControlUp booth ...
Bayer has billed Lynkuet as its next major pharma launch, saying it is due to start rolling out in the US later this month, ...
The 24GB of DDR5 RAM gives you serious multitasking headroom that most budget laptops can’t match: You can run virtual ...
Unified application intelligence is helping enterprises manage mixed workloads, reduce silos and streamline operations across ...
XDA Developers on MSN
Canonical's MicroCloud turned out to be an amazing addition to my home lab
But for folks on the hunt for a free home server platform that’s adept at running VMs and containers, MicroCloud is ...
The motorists wrote into the Guardian newspaper to say they are hostage in a repair shop and won’t be released over a debt ...
StockStory.org on MSN
The Top 5 Analyst Questions From AMN Healthcare Services’s Q3 Earnings Call
AMN Healthcare Services’ third quarter was marked by a positive market reaction, reflecting stronger-than-expected results ...
Microsoft Corp. is infusing artificial intelligence agents into Azure Copilot to turbocharge cloud operations with agentic ...
Kepler Cheuvreux analyst Sven Sauer said the order composition continues to support higher-margin programmes, particularly in the VMS unit, where Q3 sales grew 12% and order intake surged 62%. Margins ...
Discover why RNKGF is a top buy in Europe’s defense sector. Explore growth drivers, earnings outlook, and a 16% upside.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results